SPARROW SPECIALTY HOSPITAL
1. Target Overview & Investment Thesis
SPARROW SPECIALTY HOSPITAL is a 30-bed suburban community hospital in INGHAM, MI with $20.9M in net patient revenue and a 12.0% operating margin. The hospital serves a payer mix of 42.0% Medicare, 3.0% Medicaid, and 55.0% commercial.
Thesis: Turnaround. Our ML models identify $1.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 12.0% to 19.3% (+736bps).
| Net Revenue HCRIS | $20.9M |
| Current EBITDA COMPUTED | $2.5M |
| Operating Margin COMPUTED | 12.0% |
| Occupancy HCRIS | 96.8% |
| Revenue / Bed COMPUTED | $697K |
| Net-to-Gross HCRIS | 36.7% |
| Distress Probability ML | 39.0% |
2. Market Context & Competitive Position
MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of 12.0% places it above the state median. Among 75 size-comparable peers (15-60 beds), the median margin is -3.3%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (15-60), prioritizing same-state peers. 75 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SPARROW SPECIALTY HOSPITAL (Target) | MI | 30 | $20.9M | 12.0% |
| TRINITY HEALTH LIVINGSTON | MI | 42 | $200.4M | 15.2% |
| MYMICHIGAN MEDICAL CENTER ALMA | MI | 49 | $142.2M | -5.9% |
| SPECTRUM HEALTH UNITED MEMORIA | MI | 45 | $129.4M | 9.7% |
| DICKINSON COUNTY HEALTHCARE SY | MI | 49 | $126.3M | -4.7% |
| PROMEDICA HICKMAN HOSPITAL | MI | 58 | $124.7M | 5.5% |
| MUNSON HEALTHCARE CADILLAC HOS | MI | 49 | $122.7M | 1.0% |
| MCLAREN CENTRAL MICHIGAN | MI | 49 | $118.9M | -35.3% |
| SPECTRUM HEALTH GERBER | MI | 25 | $116.2M | 16.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $439K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $418K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $414K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $254K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $13K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $2.5M |
| + RCM Uplift | +$1.5M |
| Pro Forma EBITDA | $4.0M |
| Current Margin | 12.0% |
| Pro Forma Margin | 19.3% |
| WC Released (1x) | $802K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $3.9M | $31.9M | 8.28x | 52.6% |
| Base (11x exit) | 10.0x | 11.0x | $3.9M | $36.4M | 9.44x | 56.7% |
| Bull Case | 9.0x | 11.0x | $3.5M | $42.7M | 12.31x | 65.2% |
| Bull (12x exit) | 9.0x | 12.0x | $3.5M | $47.6M | 13.73x | 68.8% |
| Bear Case | 11.0x | 10.0x | $4.2M | $23.0M | 5.42x | 40.2% |
| Bear (11x exit) | 11.0x | 11.0x | $4.2M | $26.6M | 6.29x | 44.4% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 75 hospitals with 15-60 beds
- Same-state prioritization (n=76)
- Comp margins: P25=-11.1% / P50=-3.3% / P75=8.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.